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Purpose: To compare the outcomes of thoracic endovascular aortic repair (TEVAR) 
with those of open repair for descending thoracic aortic aneurysms (DTAA). Mate-
rials and Methods: We compared the outcomes of 114 patients with DTAA and 
proximal landing zones 3 or 4 after TEVAR to those of 53 patients after conven-
tional open repairs. Thirty-day and late mortality were the primary endpoints, and 
early morbidities, aneurysm-related death, and re-intervention were the secondary 
endpoints. Results: The TEVAR group was older and had more incidences of dis-
secting aneurysm. The mean follow-up was 36±26 months (follow-up rate, 97.8%). 
The 30-day mortality in the TEVAR and open repair groups were 3.5% and 9.4% 
(p=0.11). Perioperative stroke and paraplegia incidences were similar between the 
groups [5.3% vs. 7.5% (p=0.56) and 7.5% vs. 3.5% (p=0.26), respectively]. Respira-
tory failure occurred more in the open repair group (1.8% vs. 26.4%, p<0.01). The 
incidence of acute kidney injury requiring dialysis was higher in the open repair 
group (1.8% vs. 9.4%, p<0.01). The cumulative survival rate was higher in the TE-
VAR group at 2 to 5 years (79.6% vs. 58.3%, p=0.03). The free from re-intervention 
was lower in the TEVAR group (65.3% vs. 100%, p=0.02), and the free from aneu-
rysm-related death in the TEVAR and open repair groups were 88.5% and 86.1% 
(p=0.45). Conclusion: TEVAR is safe and effective for treating DTAAs with im-
proved perioperative and long-term outcomes compared with open repair.
Key Words:   Aortic aneurysm, aorta, descending, endovascular procedures, cardio-
vascular surgical procedures, outcome assessment
INTRODUCTION
Since, the report on the first successful open repair of a thoracic aortic aneurysm 
with a prosthetic graft in 1953 by De Bakey and Cooley,1 an open surgical repair for 
treating thoracic aortic aneurysms has been the gold standard for 50 years. However, 
open aneurysm repair is associated with significantly high complications, includ-
ing intraoperative and postoperative death, hemorrhage, stroke, and paraplegia. To 
reduce mortality and morbidity, this surgical procedure has been refined, and a 
multimodal approach has evolved to maximize organ protection. Nevertheless, it 
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proved by the Institutional Review Board of Yonsei Univer-
sity College of Medicine (No. 4-2014-0033), and individual 
informed consent was waived. 
Endpoints and definitions
Outcome criteria and definitions were based on recom-
mended reporting standards for TEVAR.7 The primary end-
points of this study were 30-day mortality and late mortality. 
The secondary endpoints were early morbidities, including 
neurologic complications such as stroke and paraplegia, re-
spiratory failure, AKI, need for dialysis, late aneurysm-relat-
ed death, and re-intervention. 
The proximal attachment zones were defined according 
to the proximal attachment site of the proximal edge of the 
covered endograft; zone 3 was defined as ≤2 cm of the left 
subclavian artery (without covering it), and zone 4 was de-
fined when the proximal extent of the endograft was >2 cm 
distal to the left subclavian artery and ended within the proxi-
mal half of the DTAA (T6 level approximating the mid-
point of the DTAA).7 Aneurysm-related death was defined 
as primary procedure-related mortality, secondary proce-
dure-related mortality, and any death related to the aortic 
graft or aneurysm rupture at any time during the follow-up. 
Respiratory failure was defined as mechanical ventilation 
for longer than 24 h, need for re-intubation, tracheostomy, or 
adult respiratory distress syndrome. AKI was defined as any 
of the following: an increase in serum creatinine by ≥0.3 
mg/dL within 48 h compared to that at baseline, an increase 
in serum creatinine to ≥1.5 times within 7 days compared to 
that at baseline, or a decrease in urine volume to <0.5 mL/
kg/h for 6 h.8
Procedural techniques
The indications of TEVAR or open repair for isolated DTAA 
were as follows: 1) maximum aortic diameter ≥55 mm; 2) 
rapid aortic enlargement (≥10 mm per year); and 3) rupture 
or impending rupture. The treatment modality was decided 
collaboratively by the interventional cardiologist and sur-
geons that were involved in the patients’ care, and it was 
based on the patients’ co-morbidities, anatomical feature of 
the lesion, and the quality of vascular access.
TEVAR
All TEVAR procedures were performed with S & G SEAL 
endovascular stent-grafts (S & G Biotech, Seongnam, Ko-
rea), Gore TAG endoprostheses (W. L. Gore & Associates, 
Inc., Flagstaff, AZ, USA), or Cook Zenith TX2 stent grafts 
has still been associated with significant mortality and cu-
mulative morbidity. 
The first application of endovascular repair for thoracic 
aneurysms was in the mid-1990s, which caused a major par-
adigm shift with regard to thoracic aortic aneurysm treat-
ment.2,3 Clinical outcomes, mortality, and major complica-
tions have been significantly improved with thoracic endo-
vascular aortic repair (TEVAR).4,5 However, little is known 
about the follow-up outcomes of thoracic aortic aneurysms 
treated with TEVAR and the outcomes of TEVAR compar-
ed with conventional open surgery in patients with descend-
ing thoracic aortic aneurysm (DTAA). Recently, Desai, et al.6 
reported that the overall survival rate at 8‒10 years was sim-
ilar between the open repair and TEVAR groups. They also 
reported that the use of TEVAR versus open repair did not 
influence late mortality in a risk adjusted Cox proportional 
hazard model.
The purpose of this study was to compare early and late 
mortality, early morbidity, and re-intervention between the 
open repair and TEVAR technique in patients with DTAA.
MATERIALS AND METHODS
Study population
From January 2006 to July 2013, 114 patients with isolated 
DTAA (proximal landing zones 3 or 4) underwent TEVAR. 
During the same period, comparators of 53 open repairs 
were identified from 96 thoracic/thoracoabdominal cases. 
The patients selected in the open repair group had a proxi-
mal anastomosis site below the left subclavian artery and 
had anatomy that was amenable to TEVAR. Exclusion crite-
ria were >80 years old, because patients exceed 80 years old 
were not usually candidate for open repair in our institute 
during the study period. Disease extended to the abdominal 
aorta, and previous history of open repair or TEVAR for th-
oracic aortic aneurysm. The following preoperative vari-
ables were retrospectively reviewed and compared for each 
group: age, gender, body surface area, history of smoking, 
diabetes mellitus, cerebrovascular accident, coronary artery 
obstructive disease, renal insufficiency, previous coronary in-
tervention, previous coronary artery bypass surgery, and pa-
thology of aortic disease. The early postoperative outcomes, 
such as 30-day mortality, paraplegia, stroke, acute kidney 
injury (AKI), and prolonged mechanical ventilation as well 
as late outcomes, including the cause of mortality, readmis-
sion, and re-intervention were reviewed. This study was ap-
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collected prospectively from the registry database, medical 
notes, and medical charts. Detailed data were collected on 
the index admission when surgery was performed. After dis-
charge, the patients were regularly followed up at 1, 3, 6, and 
12 months and yearly at outpatient clinics or by mail and 
telephone. Additionally, a CT angiogram was performed at 
least once a year for 5 years and every 2 or 3 years thereafter. 
Statistical analysis
All data are expressed as mean±SD or frequency and per-
centage. Continuous variables were compared by use of the 
t-test and categorical variables were compared by use χ2 or 
Fisher’s exact test. Early outcomes and late outcomes were 
compared using univariate statistics including the Student t-
test for continuous data and Fisher’s exact test for categorical 
data. Overall survival and free from aneurysm-related death 
and free from re-intervention were analyzed using the Ka-
plan-Meier survival technique, and the log-rank test (with 
adjustment for trend) was used for comparisons. A Cox pro-
portional hazards regression model was used to calculate the 
odd ratios (ORs) and confidence intervals (CIs) of the vari-
ous groups while adjusting for pre- and intraoperative fac-
tors including procedure techniques. The model selection 
was first done with a backward stepwise method, and vari-
ables with p-values of less than 0.05 were retained in the 
model as independent predictors. The model was then con-
firmed using a forward stepwise selection. Statistical calcula-
tions were performed using a computerized statistical pro-
gram (SPSS 11.0, SPSS Inc., Chicago, IL, USA). p-values≥0.05 
were considered as statically significant. All p-values are 
two-tailed.
RESULTS
 
Patient characteristics
Patients in the TEVAR group were significantly older (65.5± 
12.9 years in TEVAR group vs. 60.1±15.9 years in open re-
pair group; p=0.02) and had a higher proportion of renal in-
sufficiency than patients in the open repair group (33.0% in 
TEVAR group vs. 15.1% in open repair group; p=0.02). Six-
ty-nine patients (41.3%) were diagnosed with dissecting 
aneurysm. The incidence of dissection aneurysm was high-
er in the TEVAR group (47.4% in TEVAR group vs. 28.3% 
in open repair group, p=0.02), and the proportion of aortic 
rupture was higher in the open repair group (1.8% in TEVAR 
group vs. 9.4% in open repair group, p=0.02). The maximal 
(Cook Endovascular, Bloomington, IN, USA). The proce-
dures were performed in a hybrid operating room, which 
could accommodate a fixed high-quality floor-mounted im-
age intensifier, transesophageal echocardiography, intravas-
cular ultrasound, neuromonitoring equipment, a cardiopul-
monary bypass pump, if necessary, and multiple movable 
viewing screens that display angiography findings usually 
after general anesthesia is administered.9 The TEVAR de-
vice was inserted through a 20 F, 22 F, or 24 F sheath, de-
pending on the device size. Vascular access for angiograms 
was obtained percutaneously usually through the right fem-
oral artery. Left carotid to subclavian artery bypass was per-
formed before TEVAR procedure, following our institu-
tional strategy, if there is significant stenosis in right ver-
tebral artery, and thoracic aneurysm was involved just after 
the origin of left subclavian artery.
Cerebrospinal fluid (CSF) drainage was also performed 
in cases where the preoperative enhanced computed tomog-
raphy (CT) angiogram showed a significant anterior spinal 
artery (the artery of Adamkiewicz) that was at risk of being 
occluded by the endovascular stent graft. Patients were in-
jected with unfractionated heparin to maintain the activated 
clotting times above 250 s. The femoral vascular access was 
then isolated for device delivery. Angiographic landmarks 
guided the device positioning and deployment. After the 
procedure, a suture-mediated closure device (PercloseTM; 
Abbott Lab., Menlo Park, CA, USA) was used for closure 
of the access site (Preclose technique).10
Open repair
All patients underwent DTAA repair via left thoracotomy. 
We used the left heart bypass technique (LHB) with a cen-
trifugal pump in 20 patients (37.7%). In these patients, the 
blood was drained from the left atrial via the inferior pul-
monary vein cannula and returned through a cannula in the 
femoral artery. The closed LHB circuit did not include a car-
diotomy reservoir, an oxygenator, or a warming device.
In 33 patients (58.8%), the proximal aortic clamping was 
judged to be technically unsafe because of proximal calcifi-
cation and thrombosis. Therefore, cardiopulmonary bypass 
was instituted, and the repair was completed in a bloodless 
surgical field with the patient under hypothermic circulato-
ry arrest. Mean circulatory arrest time was 18.6 min (range, 
14–33 min).
Data collection and clinical follow-up 
Preoperative, intraoperative, and postoperative data were 
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need for dialysis (1.8% vs. 9.4%, p=0.01) were significantly 
higher in the open repair group. Late mortality was 12.7% 
and 14.6% in the TEVAR and open repair groups, respec-
tively (p=0.75). Late aneurysm related death occurred more 
in the TEVAR group (10.0% vs. 4.2%) but did not reach sta-
tistical difference (p=0.35). More patients who underwent 
TEVAR needed re-intervention significantly (21.8% vs. 
2.1%, p<0.01). The Kaplan-Meier analysis revealed that free 
diameters of the aneurysms were larger in the open repair 
group (56.2 mm in TEVAR group vs. 60.0 mm in open re-
pair group, p=0.04). Table 1 summarizes the patients’ base-
line characteristics and aortic pathologies.
Full cardiopulmonary bypass with circulatory arrest was 
predominantly performed during open repair (33/53, 58.5%), 
and the left atrial-femoral artery bypass was used for the re-
maining patients (20/53, 37.7%). A mean of 1.32±0.50 stents 
were used during TEVAR, and 14 of the patients (12.3%) 
underwent preoperative left carotid-subclavian bypass. Pre-
operative CSF drainage was performed in 67 patients (58.8%) 
of the TEVAR group and in 42 patients (79.2%) of the open 
repair group. Table 2 summarizes the operative data.
Endpoints
The completed follow-up rate was 97.8%, and the mean fol-
low-up duration was 36±26 months. Overall, 30-day mortal-
ity was 3.5% and 9.4% in the TEVAR and open repair gr-
oups, respectively (p=0.14). Paraplegia occurred more in 
the open repair group (3.5% vs. 7.5%) but did not reach sta-
tistical difference (p=0.27). There was no difference in the 
incidence of stroke between the two groups (5.3% vs. 7.5%, 
p=0.73). The incidence of respiratory failure (1.8% vs. 26.4%, 
p<0.01), postoperative AKI (4.4% vs. 17.0%, p<0.01), and 
Table 1. Patient Characteristics
TEVAR (n=114) Open repair (n=53) p value
Age, yrs 65.5±12.9 60.1±15.9 0.02
Female, n (%) 27 (23.7) 16 (30.2) 0.37
Smoker, n (%) 46 (40.4) 16 (30.2) 0.3
Body surface area, m2/kg 1.7±0.2 1.7±0.2 0.77
Diabetes mellitus, n (%) 10 (8.8) 7 (13.2) 0.38
Hypertension, n (%) 84 (73.7) 40 (75.5) 0.81
Previous CVA, n (%) 4 (3.5) 3 (5.7) 0.52
CAOD, n (%) 13 (11.4) 7 (13.2) 0.74
Renal insufficiency, n (%) 37 (33.0) 8 (15.1) 0.02
Previous PTCA, n (%) 5 (4.4) 4 (7.5) 0.4
Previous CABG, n (%) 4 (3.5) 1 (1.9) 0.57
Aortic pathology
Medial degeneration, n (%) 50 (43.9) 27 (50.1) 0.08
Dissecting aneurysm, n (%) 54 (47.4) 15 (28.3) 0.02
Traumatic dissection, n (%) 7 (6.1) 3 (5.7) 0.9
Marfan syndrome, n (%) 1 (0.9) 3 (5.7) 0.06
Aortic rupture, n (%) 2 (1.8) 5 (9.4) 0.02
Lesion
Zone 3, n (%) 64 (56.1) 37 (69.8) 0.1
Zone 4, n (%) 50 (44.7) 16 (30.2) 0.07
Aneurysm maximum size (mm) 56.2±9.3 60.0±13.615 0.04
TEVAR, thoracic endovascular aortic repair; CVA, cerebrovascular accident; CAOD, coronary artery obstructive disease; PTCA, percutaneous transluminal 
coronary angioplasty; CABG, coronary artery bypass grafting.
Table 2. Operative Characteristics
Operative data
TEVAR 114
No. of device implanted, n 1.32±0.50
Previous left carotid-subclavian bypass, n (%) 14 (12.3)
CSF drainage, n (%) 67 (58.8)
Open repair 53
Left heart bypass, n (%) 20 (37.7)
Cardiopulmonary bypass time (min) 59.4±23.8
Full bypass with circulatory arrest, n (%) 33 (58.5)
Cardiopulmonary bypass time (min) 153.2±51.6
Circulatory arrest time (min) 18.6±8.6
Full bypass without circulatory arrest, n (%) 2 (3.8)
Cardiopulmonary bypass time (min) 115.5±54.4
CSF drainage, n (%) 42 (79.2)
TEVAR, thoracic endovascular aortic repair; CSF, cerebrospinal fluid.
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free from re-intervention was significantly higher in the open 
repair group (log rank test, p=0.02) (Fig. 1). There were 24 
patients (21.8%) with aortic re-intervention, including en-
doleak (18.2%) and retrograde dissection (3.6%), in the TE-
VAR group at the follow-up. One patient with endoleak and 
4 patients with retrograde dissection were treated surgically. 
The variables for the Cox proportional hazard model that 
identified the predictors of aneurysm-related death included 
age, gender, history of smoking, hypertension, diabetes, cor-
onary artery obstructive disease, renal insufficiency, aortic pa-
thology, and the use of TEVAR versus open repair. The use of 
TEVAR and open repair did not influence aneurysm-related 
death (OR 1.557; 95% CIs 0.574–4.152; p=0.38). Old age 
from re-intervention was significantly higher in the open re-
pair group (log rank test, p=0.02) (Fig. 1). There were 24 pa-
tients (21.1%) with aortic re-intervention, including endole-
ak (17.4%) and retrograde dissection (3.5%), in the TEVAR 
group at the follow-up. One patient with endoleak and 4 pa-
tients with retrograde dissection were treated surgically. Ta-
ble 3 summarizes the early and late outcomes (see discussion 
in the details of cases of late mortality).
The cumulative survival rate at 3 to 5 years was signifi-
cantly higher in the TEVAR group than in open repair pa-
tients (log rank test, p=0.03) (Fig. 1). However, free from 
aneurysm-related death was similar between the groups at 3 
to 5 years (p=0.45). The Kaplan-Meier analysis revealed that 
Fig. 1. Rates of overall survival, free from aorta-related death, and free from re-intervention. TEVAR, thoracic endovascular aortic repair.
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  patients at risk 1 year 3 years 5 years
TEVAR 91.8±2.5% 86.7±5.7% 79.6±4.9%
(n=103) (n=57) (n=24)
Open repair 81.8±5.5% 68.0±10.0% 58.3±12.5%
(n=22) (n=9) (n=4)
Event-free rate
  patients at risk 1 year 3 years 5 years
TEVAR 90.5±2.7% 76.9±4.6% 65.3±6.0%
(n=94) (n=50) (n=21)
Open repair 100% 100% 100%
(n=53) (n=9) (n=4)
Event-free rate
  patients at risk 1 year 3 years 5 years
TEVAR 92.6±2.4% 90.77±2.7% 88.5±3.0%
(n=103) (n=57) (n=24)
Open repair 86.1±4.9% 86.1±4.9% 86.1±4.9%
(n=22) (n=9) (n=4)
Months after procedure
Months after procedure
Months after procedure
p value=0.032 (log-rank)
p value=0.021 (log-rank)
p value=0.455 (log-rank)
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more risks. In our present study, the TEVAR patients were 
older than the open repair patients by almost 0.5 decade, and 
the TEVAR patients had a higher incidence of preoperative 
renal insufficiency. These differences occurred initially, be-
cause TEVAR was primarily used in high-risk patients who 
could not tolerate conventional open repair. The re-inter-
vention rate and continued presence of complications, such 
as endoleaks, was higher in the TEVAR group, and free from 
aneurysm-related death at 3 to 5 years was not different be-
tween the groups, even though overall survival rate was bet-
ter in the TEVAR group.
Treatment of DTAA is challenging. Although open repair 
for DTAA has become a refined surgical procedure, it has 
nevertheless been associated with significant perioperative 
mortality and neurologic complication. In recent series from 
high-volume centers of excellence, mortality and neurologic 
morbidity rates were shown to range from 5.4–7.2% for 
mortality, 2.1–6.2% for permanent stroke, and 0.8–2.3% for 
permanent paraplegia.11,12 The highly invasive nature of open 
repair necessitates a lesser invasive method for treating de-
scending thoracic aortic disease. Since introduction of TE-
VAR, many reports have demonstrated that it is a safe and 
feasible alternative to conventional repair. The perioperative 
results for the three stent graft trials in the TEVAR arms sh-
owed rates of 1.9–2.1% for mortality, 2.4–4% for stroke, and 
1.3–3% for permanent paraplegia.4,13,14
AKI is an another important complication and regarded 
as a marker of increased early or late morbidity and mortal-
ity after TEVAR or open repair for DTAA.15 The overall in-
cidence of AKI after aortic surgery has been reported to be 
high compared with other cardiac surgeries.16 In addition to 
preoperative risk factors, thoracic aortic surgery itself is an 
independent risk factor for AKI because of the complexity 
of the procedure, which includes circulatory arrest.17 In our 
was the only independent predictor for aneurysm-related 
death (OR 1.048; 95% CIs 1.004–1.094; p=0.03) (Fig. 2).
DISCUSSION
This is a retrospective study assessed the efficacy and suit-
ability of TEVAR in patients with isolated DTAA. The ma-
jor finding of this study, based on 114 consecutive patients 
who underwent TEVAR, is that early mortality and neuro-
logic complications did not differ between the TEVAR and 
open repair groups. However, the incidence of postoperative 
AKI and respiratory failure were significantly lower in the 
TEVAR group. In terms of late outcomes, the overall surviv-
al rate at 3 to 5 years was significantly higher in the TEVAR 
group, even though the patients of the TEVAR group had 
Table 3. Early and Late Outcomes 
 Variables 
TEVAR
(n=114)
Open repair
(n=53)
p value
Early outcomes, n (%) 
30-day mortality 4 (3.5) 5 (9.4) 0.14
Paraplegia 4 (3.5) 4 (7.5) 0.27
Stroke 6 (5.3) 4 (7.5) 0.73
Respiratory failure 2 (1.8) 14 (26.4) <0.01
Acute kidney injury 5 (4.4) 9 (17) 0.01
Need for dialysis 2 (1.8) 5 (9.4) 0.03
Late outcomes*
Late death 14 (12.7) 7 (14.6) 0.75
Late aneurysm-related death 11 (10.0) 2 (4.2) 0.35
Re-intervention 24 (21.8) 1 (2.1) <0.01
Endoleak 20 (17.4) -
Retrograde dissection 4 (3.5) -
Leakage - 1 (2.1)
TEVAR, thoracic endovascular aortic repair.
*Outcomes after 30 days postoperatively.
Fig. 2. Predictors of aneurysm-related death. HTN, hypertension; DM, diabetes mellitus; CAOD, coronary artery obstructive disease; TEVAR, thoracic endo-
vascular aortic repair; CI, confidence interval.
0.1                                                               1                                                                 10
Odd ratios 95% CIs p value
Age 1.05 1.004–1.094 0.03
Female 2.45 0.383–7.151 0.10
Smoker 2.51 0.889–7.062 0.08
HTN 1.30 0.430–3.928 0.64
DM 0.66 0.149–2.922 0.58
CAOD 1.82 0.589–5.637 0.30
Renal insufficiency 1.03 0.387–2.733 0.96
Dissecting aneurysm 1.24 0.470–3.274 0.66
TEVAR vs. open repair 1.56 0.574–4.152 0.38
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which mostly occurred in the early running period of TE-
VAR. All patients with retrograde dissection underwent sur-
gical treatment, and 3 of these patients died 30 days postop-
eratively.
TEVAR also seems to be associated with the reduction of 
long-term mortality rates. The midterm follow-up of pa-
tients revealed a significant benefit in cumulative survival 
rates in the TEVAR group (77%) compared to that in the 
open repair group (58.4%), even though patients who under-
went TEVAR were older than those who underwent open 
repair. There were 8 late deaths (3 in the TEVAR group and 5 
in the open repair group) unrelated to aortic disease. In the 
TEVAR group, 2 patients died because of malignant tumor 
and 1 patient died with unknown reason. Among 5 deaths in 
the open repair group, 2 patients died because of pneumonia 
and sepsis, 1 patient malignant tumor, and 2 patients, who 
needed dialysis just after open repair, died with unknown 
reasons. A higher incidence of postoperative AKI and respi-
ratory failure can affect long-term survival rates. Piffaretti, 
et al.25 reported that AKI was also associated with increased 
late mortality. We thought that higher rate of AKI and pneu-
monia after open repair could affect long-term survival and 
late death. Little is known about the mid-term or long-term 
outcomes after TEVAR in patients with DTAA. Recently, 
Desai, et al.6 reported outcomes similar to ours: the overall 
survival rate at 8–10 years was similar between the open re-
pair and TEVAR groups, even though the TEVAR group was 
older and had more preoperative comorbidities than the 
open repair group. In our study, free from aneurysm-related 
death at 3 to 5 years was not different between the groups, 
even though overall survival rate was better in the TEVAR 
group. 
The late aneurysm-related death rate was higher in TE-
VAR group (10.0% vs. 4.2%, p=0.35), although did not 
reach statistical difference. There were 11 late aneurysm-re-
lated deaths after TEVAR, which includes 3 deaths related to 
retrograde dissection, 4 related to surgical conversion due 
to endoleak, and 4 related to aneurysm rupture due to endole-
ak. There were 2 late aneurysm-related death after open re-
pair, which includes 1 death related to rupture of anastomo-
sis site, and 1 related to rupture of abdominal aortic aneu-
rysm. As mentioned earlier, retrograde dissection and endo-
leak in the present study were significant complications, 
leading to catastrophic results. These significant complica-
tions may contribute to our relatively poor result of an aneu-
rysm-related death rate after TEVAR. However, most of the 
late aneurysm-related deaths (8/11) occurred in patients who 
present study, 33 patients (58.5%) in the open repair group 
underwent total circulatory arrest with hypothermia, and 
AKI occurred in 9 patients (17%) of the group, including 5 
patients (9.4%) who required dialysis. A wide range of inci-
dence of renal dysfunction has been reported in patients un-
dergoing TEVAR. Pisimisis, et al.18 reported that 11.9% of 
patients undergoing TEVAR had postoperative AKI. In our 
study, 5 TEVAR patients (4.4%) had an AKI with 2 requir-
ing dialysis. Although there was a higher incidence of pre-
operative renal insufficiency in TEVAR patients, the incid-
ence of postoperative AKI was lower in the TEVAR patients.
Respiratory failure was a major complication, especially 
after open repair. It affects postoperative morbidity and mor-
tality, resulting in prolonged hospitalization. In addition to 
thoracotomy, cardiopulmonary bypass and hypothermia in-
duced a systemic inflammatory reaction attributed to postop-
erative respiratory failure.19 Because of its less invasive pro-
cedure, respiratory failure was a relatively rare complication 
after TEVAR compared with open repair.5,6 In our study, 14 
open repair patients (22.6%) developed respiratory failure 
compared with 2 patients (1.8%) in the TEVAR group.
Although the use of TEVAR has rapidly increased because 
of improved perioperative mortality and morbidity rates, 
there are no long-term data regarding the prevention of pre-
mature death using this technique. Especially, the durability 
and long-term complication rates of TEVAR have not yet 
been determined. Recent publications have cautioned that 
high re-intervention is associated with TEVAR.6 In our study, 
a significantly higher rate of re-intervention was associated 
with the TEVAR group (24 patients, 20.1%). The reasons for 
re-intervention were endoleak (20 patients, 17.4%) and retro-
grade dissection (4 patients, 3.5%). Both endoleaks and ret-
rograde dissection after TEVAR potentially predisposes pa-
tients to catastrophic adverse events such as aneurysm pro-
gression and mortality.20 In the initially published studies on 
TEVAR, endoleaks after TEVAR seemed markedly less sig-
nificant than that of aneurysms of the infra-renal aorta, how-
ever, it soon became obvious that endoleaks after TEVAR 
are a serious complication.21,22 Endoleak after TEVAR poten-
tially predisposes patients to catastrophic adverse events such 
as aneurysm progression and mortality.20
The clinical importance of retrograde dissection of the as-
cending aorta after TEVAR has recently been developed as 
a clinical experience, and applications of TEVAR have been 
expanded. Previous studies have reported mortality rates 
ranging from 27% to 57%.23,24 In the present study, retrogr-
ade dissection was found to develop in 4 TEVAR patients, 
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